Cite
HARVARD Citation
Sazonovs, A. et al. (n.d.). OTU-002 HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in crohn's disease. Gut. pp. A52-A53. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sazonovs, A. et al. (n.d.). OTU-002 HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in crohn's disease. Gut. pp. A52-A53. [Online].